In this study, high levels of MMP-9, PTGDS, SLC26A8, and CD160 and reduced levels of TLR5 protein in patients with IBD (identified using WB and immunofluorescence analysis) suggest that these are clinically significant in IBD. The gene discussed is TLR5; the disease is inflammatory bowel disease.